Cell Therapy Limited – Trademark Portfolio
Entity Type: 99
Cell Therapy Limited holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INNATELY.
The Maynard Centre
Block CD1, Room 1:62, Forest Farm Industrial Estate, Longwood Drive, Cardiff
Showing of trademarks Trademarks
Trademark Classifications
Cell Therapy Limited's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Cell Therapy Limited have?
Cell Therapy Limited has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does Cell Therapy Limited file in?
Cell Therapy Limited files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services), Class 10 (Medical Apparatus), Class 38 (Telecommunications). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Cell Therapy Limited's most well-known trademarks?
Cell Therapy Limited's registered trademark portfolio includes well-known marks such as INNATELY. These are among 1 currently registered trademark in the portfolio.
What is Cell Therapy Limited's trademark registration success rate?
Cell Therapy Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.